Seasonal flu in the midst of the COVID-19 pandemic threatens to overwhelm practitioners, hospitals and the health care system.
News from the FDA/CDC
The drug going to clinical trials, ARDS-003, would “dampen the cytokine release” and prevent development of ARDS.
“This appears to be pretty clear-cut evidence of reinfection because of sequencing and isolation of two different viruses.”
“It offers a lot of opportunities for us to study potentially early ME/CFS and how it develops, but in addition, a lot of the research that has...
The authorization allows the plasma to be distributed in the U.S. and administered by health care providers.
Blacks have higher rates of COVID-19 infection, hospitalization, and death than Whites.
Physicians and patients discuss common concerns with telemedicine.
As with the uncoordinated and chaotic national response to the COVID-19 pandemic, higher education has no clear guidance or set of standards to...
Each week we interview key opinion leaders involved in various aspects of blood and cancer. In this episode